Anxiety Treatment for Kids: What the Evidence Says About Therapy vs. Medication

Your 9-year-old has been refusing to go to school. She cries every Sunday night anticipating the week ahead. Her pediatrician has referred her to a therapist, and now you’re sitting in an intake appointment being asked to sign forms. You don’t know if this is the right treatment. You’re not sure what questions to ask.

Or perhaps a different scenario: your son’s therapist has recommended adding medication, and you want to understand what that means, what the evidence says, and how to evaluate whether it makes sense for your child.

Anxiety is the most common mental health condition in childhood. The National Institute of Mental Health estimates that approximately 31.9% of adolescents will meet criteria for an anxiety disorder at some point. Despite this prevalence, treatment quality varies widely — and many families accept the first recommendation without understanding what the options are or what the research supports.

This article gives you the framework.

Key Takeaways

• Cognitive Behavioral Therapy (CBT) is the consensus first-line treatment for childhood anxiety and has the strongest overall evidence base.
• Exposure-based therapy — a specific CBT approach — has the most robust evidence for specific phobia, social anxiety disorder, and generalized anxiety disorder in children.
• SSRIs (typically sertraline or fluoxetine) are appropriate second-line additions when CBT alone is insufficient, particularly for moderate-to-severe anxiety.
• The landmark CAMS trial (2008) found that combined CBT + sertraline produced a 80.7% response rate vs. 59.7% for CBT alone and 54.9% for sertraline alone.
• Younger children, mild-to-moderate presentations, and specific phobias typically respond well to CBT alone. Severe, generalized, or treatment-resistant anxiety typically warrants combination treatment.
• Duration matters: effective CBT for childhood anxiety typically requires 12–20 sessions, not 4–6.

The Evidence Hierarchy for Childhood Anxiety Treatment

Before comparing options, it helps to understand how researchers evaluate treatments. The gold standard is a randomized controlled trial (RCT). When multiple RCTs show consistent results, that’s the strongest form of evidence. Single case studies or clinical opinion are the weakest. What follows reflects where each childhood anxiety treatment falls in that hierarchy.

Cognitive Behavioral Therapy (CBT)

CBT is the most studied psychological treatment for childhood anxiety by a wide margin. The core premise is that anxiety involves distorted thinking patterns and avoidance behaviors that reinforce each other. CBT addresses both by helping children identify anxious thoughts, evaluate them more accurately, and gradually face feared situations rather than avoiding them.

A 2015 meta-analysis by Reynolds et al. in Journal of Clinical Child & Adolescent Psychology analyzed 55 RCTs and found that CBT produced significantly better outcomes than waitlist control conditions, with effect sizes in the moderate-to-large range. About 56–59% of children who complete CBT no longer meet criteria for their anxiety disorder at the end of treatment.

CBT for children typically looks different from CBT for adults: it is more behavioral, more playful, involves parents actively (especially for younger children), and is shorter in duration (12–16 sessions is typical for mild-to-moderate cases).

Exposure-Based Therapy

Exposure therapy is the most evidence-supported component of CBT for anxiety specifically. The mechanism: gradual, repeated contact with feared situations (in imagination or in reality) without the feared consequence occurring. Over time, the brain learns that the feared stimulus is not as dangerous as anticipated — a process called extinction learning.

For specific phobia (e.g., needles, dogs, vomiting), intensive exposure protocols have produced remarkable results. A 2017 study by Ollendick et al. in Journal of Clinical Child & Adolescent Psychology found that a single-session intensive exposure treatment for specific phobia produced clinically significant improvement in 55% of children at post-treatment and 65% at 6-month follow-up.

For social anxiety disorder — one of the most common and most impairing anxiety presentations in adolescents — exposure to social situations with response prevention (e.g., not seeking reassurance afterward) is the central mechanism of effective CBT programs like the Coping Cat curriculum and Social Effectiveness Therapy for Children (SET-C).

A critical point for parents: not all therapists who say they do CBT actually use exposure consistently. Research by Whiteside et al. (2020) in Behavior Therapy found that exposure was the active ingredient most strongly predicting outcome, yet many therapists practicing “CBT” used relatively little exposure. It is appropriate to ask a therapist directly: “How much of our sessions will involve exposure work?”

SSRIs for Childhood Anxiety

Selective serotonin reuptake inhibitors — primarily sertraline (Zoloft) and fluoxetine (Prozac) — are the best-evidenced medications for childhood anxiety disorders. They are not habit-forming, are not sedating at typical doses, and act by modulating serotonin signaling in circuits involved in threat appraisal and fear learning.

The FDA has not approved SSRIs specifically for generalized anxiety disorder, social anxiety disorder, or specific phobia in children (as opposed to OCD, where fluvoxamine is approved for ages 8+). However, they are prescribed off-label with substantial research support.

The CAMS (Child/Adolescent Anxiety Multimodal Study) trial, published in 2008 in the New England Journal of Medicine (Walkup et al.), is the landmark study. It randomized 488 children ages 7–17 with separation anxiety, generalized anxiety disorder, or social anxiety disorder to CBT alone, sertraline alone, combined treatment, or placebo. Results at 12 weeks:

• Combined CBT + sertraline: 80.7% response rate
• CBT alone: 59.7%
• Sertraline alone: 54.9%
• Placebo: 23.7%

All three active treatments significantly outperformed placebo. Combined treatment significantly outperformed either monotherapy. The differences were especially pronounced in children with more severe baseline anxiety.

Concerns parents commonly raise about SSRIs for children include:

The black box warning: SSRIs carry an FDA black box warning about increased risk of suicidal ideation in children and adolescents, added in 2004. It is important to understand what this means: the warning is based on pooled data showing a small increase in suicidal thoughts (not completed suicides), from approximately 2% in placebo groups to 4% in SSRI groups. The American Academy of Child & Adolescent Psychiatry (AACAP) maintains that for most children, the benefits of treated anxiety outweigh this risk, particularly when combined with appropriate monitoring.

Personality change: At appropriate doses for anxiety, SSRIs do not typically produce personality changes. Dose matters significantly — the doses used for anxiety in children are generally lower than those used for depression.

Dependency: SSRIs are not controlled substances and are not habit-forming in the way benzodiazepines are. Discontinuation requires a gradual taper to avoid discontinuation symptoms, but this is different from physical addiction.

Combination Treatment

The CAMS data makes a clear case: for moderate-to-severe childhood anxiety, combined CBT + SSRI outperforms either treatment alone. This has been replicated in subsequent research. A 2019 meta-analysis by Wang et al. in JAMA Psychiatry found that combination treatment was associated with the highest response rates across anxiety disorders in youth.

When to consider combination from the start:

• Severe functional impairment (school refusal, inability to participate in daily activities)
• Anxiety accompanied by significant depression
• Previous failure to respond to adequate CBT
• Presentation suggests OCD (which generally requires medication alongside CBT from the beginning)

For school refusal specifically — one of the most functionally impairing expressions of childhood anxiety — school refusal and anxiety requires an integrated approach that typically involves both behavioral intervention and, in severe cases, pharmacological support.

Treatment Comparison Table

Treatment	Evidence Level	Best-Supported Ages	Typical Duration	What Parents Should Ask
CBT (general)	Strong — multiple RCTs and meta-analyses	6–17 years; adaptations exist for 4–5	12–20 sessions (not 4–6)	“What CBT protocol do you use? Is it manualized?”
Exposure-based therapy	Very strong — strongest individual component	5–17 years; intensive formats work well for older children	Can be as few as 1–5 sessions for specific phobia; 12–16 for social/generalized	”How much exposure work do we do? Will my child be actively facing feared situations?”
SSRI alone	Moderate-strong — effective, but less than combination	6–17 years (prescriber judgment, no lower age floor in evidence)	Minimum 6–12 months; do not stop early if responding	”Why are we starting with medication before therapy? What’s the monitoring plan for side effects?”
CBT + SSRI combined	Strongest — CAMS trial + replications	7–17 years (CAMS range)	CBT component: 12–16 sessions; SSRI: 12+ months	”At what point would we consider adding the other component if one alone isn’t working?”

What Does Not Have Good Evidence

Benzodiazepines for long-term childhood anxiety: Benzodiazepines (lorazepam, clonazepam, alprazolam) produce rapid, reliable reduction in acute anxiety and are appropriate for specific short-term uses (e.g., pre-procedure anxiety). They are not appropriate for ongoing treatment of childhood anxiety disorders. They do not address underlying mechanisms, interfere with extinction learning that makes exposure therapy work, and carry real dependence risk. AACAP guidelines do not recommend benzodiazepines for routine management of childhood anxiety disorders.

Play therapy for anxiety: General play therapy — non-directive, relationship-based approaches — has limited evidence for childhood anxiety disorders specifically. It is not equivalent to CBT and should not be substituted for it. This is different from play-based delivery of CBT techniques, which is appropriate and common for younger children.

Herbal supplements: Despite widespread marketing, no herbal supplement has adequate evidence for childhood anxiety. Melatonin has some evidence for sleep onset, but sleep disturbance and anxiety are different problems.

How to Evaluate What Your Child Is Being Offered

If you are being offered treatment for your child’s anxiety, these questions help you evaluate quality:

1. “What specific type of therapy will this be, and is it evidence-based for childhood anxiety?” (CBT and exposure-based approaches are; many others have limited evidence)
2. “How many sessions do you typically recommend, and what does that include?” (Fewer than 12 sessions for non-specific-phobia anxiety should raise questions)
3. “Will parents be involved in sessions, and how?” (Parent involvement is associated with better outcomes, especially for children under 12)
4. “What is your training in CBT for anxiety specifically?” (Child anxiety treatment is a specialization; general therapy training is not sufficient)
5. If medication is recommended: “Why now rather than after a CBT trial? What is your monitoring protocol for side effects?”

Understanding when kids should start therapy and how to evaluate a therapy referral is covered in more depth if you’re navigating that question alongside the treatment decision.

If your child’s anxiety presentation overlaps with attention or behavioral concerns, the research on childhood anxiety vs. ADHD and ADHD medication research provide relevant comparative context, since diagnostic clarity affects treatment selection.

What to Watch for Over the Next 3 Months

If your child is starting CBT: Progress in CBT for anxiety often looks worse before it looks better. Exposure is uncomfortable — that’s the point. At 4 weeks, check whether sessions include active exposure work, not just discussion. By 8 weeks, you should see some reduction in avoidance behaviors. Full response typically takes 12–16 sessions. If there’s no movement at 16 sessions with a qualified provider, discuss adding an SSRI or reassessing the diagnosis.

If your child is starting an SSRI: The first 2–4 weeks are the monitoring period. Check in about sleep changes, appetite, agitation, and any suicidal ideation. Most side effects emerge early and resolve. Therapeutic effect for anxiety typically requires 4–6 weeks at adequate dosage. Do not stop medication early because of initial side effects without consulting the prescriber.

If your child is doing combined treatment: Both components need to be active. If the CBT is not including exposure, it is not doing its job regardless of what the medication is doing. Monitor both.

FAQ

Q: My child’s pediatrician wants to start medication before a therapy evaluation. Is that appropriate? For mild-to-moderate childhood anxiety, most guidelines recommend an adequate CBT trial before medication. If your pediatrician recommends starting medication first, it is reasonable to ask for a referral to a child psychiatrist or therapist before starting, unless the presentation is severe enough that waiting for therapy would cause significant harm.

Q: How do I find a therapist who actually does evidence-based CBT? Ask specifically: “Are you trained in CBT for childhood anxiety? Do you use a manualized protocol?” Look for training in specific programs: Coping Cat, FRIENDS, CALM (Children and Adults with Anxiety and Learning), or equivalent. The Association for Behavioral and Cognitive Therapies (ABCT) provider directory filters by specialty.

Q: My child refuses to do therapy. What can we do? Refusal to engage in therapy is common in anxious children and is itself a manifestation of anxiety. Motivational approaches, parent-led coaching at home, and starting with the least threatening exposure work are strategies therapists with specific pediatric training will use. Telehealth can also reduce the barrier for children with social anxiety. If therapy remains impossible due to severity, medication may be warranted as a first step to enable engagement.

Q: Will my child need to be on medication forever? The goal is time-limited treatment. For anxiety, most guidelines recommend continuing an SSRI for at least 6–12 months after significant response, then considering a slow taper while continuing any protective behavioral strategies. Many children do not require indefinite treatment. Recurrence rates after stopping treatment vary by severity of the initial presentation.

Q: Is therapy covered by insurance for childhood anxiety? Mental health parity laws require insurance plans that cover mental health at all to cover it at parity with physical health. In practice, coverage is variable. The Mental Health Parity and Addiction Equity Act (MHPAEA) provides protections — if you are being denied coverage that would be approved for physical health treatment, you can appeal and reference MHPAEA.

Q: What’s the difference between CBT and psychodynamic or talk therapy? CBT is structured, present-focused, skill-building, and uses specific techniques (thought records, exposure hierarchies, behavioral experiments). Psychodynamic or “talk” therapy explores underlying relational and developmental patterns. The evidence base for anxiety disorders in children strongly favors CBT. Psychodynamic approaches may have a role for other presentations but are not the recommended first-line approach for anxiety.

---

About the author Ricky Flores is the founder of HiWave Makers and an electrical engineer with 15+ years of experience building consumer technology at Apple, Samsung, and Texas Instruments. He writes about how kids learn to build, think, and create in a tech-saturated world. Read more at hiwavemakers.com.

---

Sources

• Ollendick, T.H., et al. (2017). One-session treatment of specific phobias in youth: A randomized clinical trial. Journal of Clinical Child & Adolescent Psychology, 46(1), 1–14.
• Reynolds, S., et al. (2015). Meta-analysis of treatment for anxiety disorders in children. Journal of Clinical Child & Adolescent Psychology, 44(2), 206–220.
• Walkup, J.T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766.
• Wang, Z., et al. (2019). Comparative effectiveness of psychological and pharmacological interventions for anxiety disorders in children: A network meta-analysis. JAMA Psychiatry, 76(11), 1101–1113.
• Whiteside, S.P.H., et al. (2020). The role of exposure in cognitive behavioral therapy for childhood anxiety disorders. Behavior Therapy, 51(1), 51–65.
• American Academy of Child & Adolescent Psychiatry. (2020). Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. AACAP.
• National Institute of Mental Health. (2023). Any anxiety disorder. nimh.nih.gov.

---